Cantitate/Preț
Produs

Cancer Gene Therapy by Viral and Non–viral Vectors: Translational Oncology

Autor MK Brenner
en Limba Engleză Hardback – 24 iul 2014
Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of viral and non-viral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. Presented in three parts, Cancer Gene Therapy by Viral and Non-viral Vectors covers: Delivery Systems * Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors * Retroviruses for Cancer Therapy * DNA Plasmids for Non-viral Gene Therapy of Cancer * Cancer Therapy with RNAi delivered by Non-viral Membrane/Core Nanoparticles Targeted Expression * Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promptors * MicroRNAs as Drugs and Drug Targets in Cancer Principles of Clinical Trials in Gene Therapy * Regulatory issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials * US Regulations Governing Clinical Trials in Gene Therapy * Remaining Obstacles to the Success of Cancer Gene Therapy Focusing on speeding the process in clinical cancer care by bringing therapies as quickly as possible from bench to bedside, Cancer Gene Therapy by Viral and Non-viral Vectors is an absolutely vital book for physicians, clinicians, researchers, and students involved in this area of medicine.
Citește tot Restrânge

Din seria Translational Oncology

Preț: 76134 lei

Preț vechi: 113105 lei
-33% Nou

Puncte Express: 1142

Preț estimativ în valută:
14570 15324$ 12137£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781118501627
ISBN-10: 1118501624
Pagini: 176
Dimensiuni: 184 x 262 x 16 mm
Greutate: 0.59 kg
Editura: Wiley
Seria Translational Oncology

Locul publicării:Hoboken, United States

Public țintă

Primary audience: Clinical and research oncologists; oncology fellow and students; medical geneticists; medical residents and students, pharmacologic research and development professionals, biomedical scientists (∼500,000 people worldwide)  Secondary audience: Generalist physicians treating cancer patients; other professionals in health care (oncology counselors, nurses, etc.); other medical scientists (∼1,000,000 people worldwide)
Course details: This book would be useful for graduate–level instruction as a main text in medical courses pertaining to gene therapy in oncology or in pharmacy school courses pertaining to drug development. This book would also be useful for university–level instruction as supplemental text in academic clinical research and biotech courses that discuss gene therapy and drug development.

Cuprins


Notă biografică

Edited by Malcolm K. Brenner, MB, BChir, PhD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA Mien-Chie Hung PhD, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Descriere

Provides insight into the progress of viral and non-viral gene therapy. This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies.